Next Steps Programs- Advancing Drug Discovery to Identify New Therapies for Acral and Uveal Melanoma

The intent of this funding strategy is to help advance translation of discoveries into the clinic by supporting:

1) needed preclinical resources and tools for the research community to identify and begin to develop new therapies and

2) infrastructure to analyze and build large datasets to identify better diagnostic and prognostic biomarkers. 

The goal of this Next Step RFP is to provide initial support to identify new therapeutic modalities including small molecules, antibodies, protein degraders, and cell therapies against validated melanoma targets specifically in acral and/or uveal melanoma.

Funding: $200,000 total 
Duration: 1-2 years 

Research Authority due date: 17.7.25

LOI (required) due date: 30.6.25 

LOIs are used for reviewer recruitment and will not be reviewed.

An invitation to submit a full application will NOT be provided after LOI submission.

Full proposal due date: 25.7.25